acetylleucyl-leucyl-norleucinal has been researched along with sodium salicylate in 1 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) |
---|---|---|---|---|---|
321 | 0 | 53 | 2,031 | 50 | 171 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McEver, RP; Pan, J; Xia, L; Yao, L | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and sodium salicylate
Article | Year |
---|---|
A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells.
Topics: Animals; Antioxidants; Aorta; Cattle; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytokines; Dexamethasone; Endothelium, Vascular; Gene Expression; Humans; Interleukin-4; Leupeptins; NF-kappa B; Oncostatin M; P-Selectin; Peptides; Pyrrolidines; Sodium Salicylate; Thiocarbamates; Umbilical Veins | 1998 |